Johnson & Johnson Halt Isn't Just A U.S. Problem
3 years, 8 months ago

Johnson & Johnson Halt Isn't Just A U.S. Problem

NPR  

Johnson & Johnson Halt Isn't Just A U.S. Problem Enlarge this image toggle caption Phill Magakoe/AFP via Getty Images Phill Magakoe/AFP via Getty Images The Johnson & Johnson vaccine pause in the U.S. – because of reports of rare cases of potentially fatal blood clots in a small number of vaccinated women – could have global ramifications. Even though the J&J vaccine so far has had very limited distribution outside of the United States, it's slated to provide more than a billion doses to the global fight against COVID. But European regulators last week launched an investigation into whether J&J's jab may cause a rare blood clotting condition in some people one to two weeks after vaccination. Sponsor Message She predicts that with J&J, "We'll resume vaccinating likely within days with better evidence-based guidance that's been reviewed by the experts at the FDA, the CDC."

Europe South Africa Johnson Covid European Sponsor Message Vaccine Doses  global  blood  johnson  jj  countries  problem  isnt  regulators  halt  pause  clots  doses  vaccine

History of this topic

J&J COVID vaccine factory forced to trash even more doses
2 years, 4 months ago

J&J COVID vaccine factory forced to trash even more doses

Associated Press  

WASHINGTON — About 135 million more doses of Johnson & Johnson’s COVID-19 vaccine from a troubled Baltimore factory will have to be destroyed due to quality problems, Congressional panel leaders said Thursday. The announcement follows a report in May that detailed how more than 400 million vaccine doses made at an Emergent BioSolutions plant had to be trashed. Johnson & …

Africa's COVID vaccine production line in jeopardy
2 years, 7 months ago

Africa's COVID vaccine production line in jeopardy

The Hindu  

Trisha shakes her head when asked if she's vaccinated. 'A massive setback for Africa's plans' In the absence of orders or commitments, Aspen is considering the repurposing of two COVID-19 production lines for the manufacture of other products. "The continent would lose its only existing COVID vaccine manufacturing capacity," Nicolaou says. Africa's major public health body, the Africa Centers for …

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report
2 years, 7 months ago

J&J Covid-19 vaccine ‘limited’ to some people after clot concerns: Report

Hindustan Times  

Johnson & Johnson’s Covid-19 vaccine was limited to use only in adults for whom other shots aren’t appropriate after an investigation of rare and potentially deadly clotting disorder that occurs in some recipients. J&J’s single-shot vaccine has been noted for its convenience compared to two-shot vaccines, especially in remote areas and in populations like the homeless who may be difficult …

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk
2 years, 7 months ago

FDA restricts Johnson & Johnson’s COVID-19 vaccine due to blood clot risk

LA Times  

Vials of the Johnson & Johnson COVID-19 vaccine are seen at a pharmacy in 2021. U.S. regulators on Thursday strictly limited who can receive Johnson & Johnson’s COVID-19 vaccine due to the ongoing risk of rare but serious blood clots. FDA officials said in a statement that they decided to restrict J&J’s vaccine after taking another look at data on …

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine
3 years ago

CDC advisers review blood-clotting risk associated with J&J’s covid-19 vaccine

Live Mint  

U.S. vaccine advisers are scheduled to consider whether to change recommendations on the use of Johnson & Johnson’s Covid-19 vaccine because of the risk of a rare but serious blood-clotting condition. The Advisory Committee on Immunization Practices will hear updates Thursday from Centers for Disease Control and Prevention officials on reports of J&J vaccine recipients experiencing blood clots combined with …

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival
3 years ago

The big vaccine pivot: Merck falters on Covid-19 shots, then makes one for rival

Live Mint  

Weeks after Merck & Co. scrapped development of its Covid-19 vaccines in January, one of its senior manufacturing officials began phoning his deputies, telling them their work on a pandemic shot wasn’t actually over. J&J’s unusual collaboration with a rival, and Merck’s speedy manufacturing run-up, reflect one of the biggest challenges of the pandemic: making enough Covid-19 vaccines to meet …

FDA panel endorses booster shot for J&J COVID-19 vaccine
3 years, 2 months ago

FDA panel endorses booster shot for J&J COVID-19 vaccine

The Hindu  

U.S. health advisors endorsed a booster of Johnson & Johnson’s COVID-19 vaccine on Friday, citing concern that Americans who got the single-dose shot aren’t as protected as those given two-dose brands. Unable to settle the best timing, the FDA’s advisory panel voted unanimously that the booster should be offered at least two months after people got their earlier shot. “It …

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters
3 years, 2 months ago

FDA advisers recommend J&J Covid-19 vaccine boosters, talk mix and match boosters

CNN  

CNN — Vaccine advisers to the US Food and Drug Administration voted unanimously Friday to recommend a booster dose of Johnson & Johnson’s vaccine at least two months after people get the first dose. The FDA’s Vaccines and Related Biological Products Advisory Committee voted 19-0 to recommend the extra dose for all recipients of the J&J Janssen vaccine, which is …

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds
3 years, 3 months ago

Two dose version of Johnson & Johnson shot 94% effective against Covid-19, study finds

CNN  

CNN — A two-dose version of Johnson & Johnson’s coronavirus vaccine provides 94% protection against symptomatic infection, the company said Tuesday – making a two-dose regimen of J&J’s Janssen vaccine comparable to a two-dose regimen of Moderna’s or Pfizer’s. “Our large real-world-evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against …

As U.S. approves booster shots, just 3.5% vaccinated in Africa
3 years, 3 months ago

As U.S. approves booster shots, just 3.5% vaccinated in Africa

The Hindu  

On September 14, WHO Director-General Dr. Tedros Ghebreyesus highlighted vaccine inequity globally, particularly in Africa, when he revealed that of the nearly 6 billion doses administered globally, only 2% of those have been in Africa; about 80% have been administered in high- and upper-middle income countries. On September 9, Dr. Matshidiso Moeti, WHO’s Africa director said that for a variety …

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month
3 years, 3 months ago

Made by Biological E, J&J's Single-Shot Covid Vaccine to Hit Market Next Month

News 18  

US Pharma giant Johnson & Johnson’s single shot vaccine manufactured by Hyderabad-based Biological E is likely to be rolled out by October, News18.com has learnt. The vaccine batches are expected to go for the final testing at the apex laboratories — Central Drugs Laboratory, Kasauli and National Centre for Cell Science, Pune — by next week. “The vaccine is likely …

South Africa will no longer send J&J vaccines to Europe, AU envoy says
3 years, 3 months ago

South Africa will no longer send J&J vaccines to Europe, AU envoy says

CNN  

CNN — An arrangement in which Johnson & Johnson Covid-19 vaccines were being shipped from South Africa to Europe has been suspended, African Union Special Envoy for Covid-19 response, Strive Masiyiwa, has said. The arrangement was reversed in part due to interventions from South African President Cyril Ramaphosa, European Commission President Ursula von der Leyen, and French President Emmanuel Macron, …

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents
3 years, 4 months ago

J&J Applies for Covid-19 Vaccine Study in Indian Adolescents

News 18  

Johnson & Johnson on Friday said it has submitted an application to the Indian drug regulator to conduct a study of its COVID-19 vaccine in adolescents aged 12-17 years. “On August 17, 2021, we submitted an application to the Central Drugs Standard Control Organisation to conduct a study of the Johnson & Johnson COVID-19 vaccine in India in adolescents aged …

South African activists slam J&J for exporting vaccines
3 years, 4 months ago

South African activists slam J&J for exporting vaccines

Associated Press  

JOHANNESBURG — Health activists in Africa have slammed Johnson & Johnson for exporting vaccines produced in South Africa to countries in Europe, which have already immunized large numbers of their people and have even donated vaccines to more needy countries. The South African activists on Tuesday called for a full disclosure of the South African government’s contracts with Johnson & …

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative
3 years, 4 months ago

Is J&J Vaccine Effective Against Delta Variant? This African Study Answers in Affirmative

News 18  

Data from a clinical trial in South Africa suggests that a single dose of the Covid-19 vaccine made by Johnson & Johnson is highly effective in preventing severe illness and death from the Delta and Beta variants of the coronavirus. As per media reports, the trial evaluated one dose of the Johnson & Johnson vaccine in nearly 500,000 health care …

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India
3 years, 4 months ago

Johnson & Johnson applies for approval of its single-dose Covid vaccine in India

Hindustan Times  

Johnson & Johnson, the 134-year-old American pharma conglomerate, has now applied to the Central Drug Standard Control Organisation of India seeking emergency use approval of its single-shot vaccine. Johnson & Johnson has approached the Central Drug Standard Control Organisation for Emergency Use Authorization for the single-dose Covid-19 vaccine "This is an important milestone that paves the way to bringing our …

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India
3 years, 4 months ago

Johnson & Johnson Withdraws Proposal for Speedy Covid Vaccine Approval in India

News 18  

The Central Drugs Standard Control Organisation said on Monday that Johnson & Johnson withdrew its proposal seeking accelerated approval of its COVID-19 vaccine in the country, without giving additional details. The drugmaker's withdrawal comes as India tackles legal challenges with manufacturers over indemnity issues, with its junior health minister saying last week that a team had been formed to engage …

Vaccine inequalty: African countries to receive six million Johnson and Johnson vaccines
3 years, 5 months ago

Vaccine inequalty: African countries to receive six million Johnson and Johnson vaccines

CNN  

CNN — Around six million doses of the single-shot Johnson & Johnson coronavirus vaccine will be delivered by the African Union to 27 African nations that have paid for the shipments through the end of August, an AU special envoy said on Thursday. Local vaccine production ‘the answer’ The balance of Africa’s vaccine requirements will come from donors including COVAX, …

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant
3 years, 5 months ago

Johnson & Johnson\'s single-dose vaccine shows promising signs against Delta variant

Deccan Chronicle  

New Jersey: Johnson & Johnson on Thursday announced that its single-shot COVID-19 vaccine showed promising signs of protection against the Delta variant rapidly spreading across the US and other countries, in a small laboratory study. "Today's newly announced studies reinforce the ability of the Johnson & Johnson COVID-19 vaccine to help protect the health of people globally," said Paul Stoffels, …

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find
3 years, 5 months ago

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find

NPR  

Johnson & Johnson's COVID Vaccine Is Effective Against The Delta Variant, Studies Find Enlarge this image toggle caption David Zalubowski/AP David Zalubowski/AP Johnson & Johnson's COVID-19 vaccine offers strong protection against the delta variant of the coronavirus, the company said Thursday. In one small laboratory study, researchers observed what happened to the blood of eight vaccinated individuals when it was …

Just Give Us the Vaccines, WHO Pleads, as Poor Countries Go Wanting
3 years, 5 months ago

Just Give Us the Vaccines, WHO Pleads, as Poor Countries Go Wanting

News 18  

Rich countries are opening up societies and vaccinating young people who are not at great risk from COVID-19, while the poorest countries cruelly lack doses, the World Health Organization said on Friday, condemning a global failure. The situation in Africa, where new infections and deaths jumped by nearly 40% last week compared to the previous week, is “so dangerous” as …

Johnson & Johnson's vaccine drive stalls out in U.S after safety pause
3 years, 6 months ago

Johnson & Johnson's vaccine drive stalls out in U.S after safety pause

India Today  

Safety concerns about Johnson & Johnson's COVID-19 vaccine along with overall flagging demand for vaccinations have slowed its U.S. rollout to a crawl, leaving close to half of the 21 million doses produced for the United States sitting unused. J&J is working with the U.S. government and health authorities to support use of its vaccine, the spokesperson said in a …

Alarm in Africa: Virus surges, vaccines grind to ‘near halt’
3 years, 6 months ago

Alarm in Africa: Virus surges, vaccines grind to ‘near halt’

Associated Press  

CAPE TOWN, South Africa — COVID-19 vaccine shipments have ground to “a near halt” in Africa while virus cases have spiked 20% over the last two weeks, the World Health Organization said Thursday, a bleak scenario for the continent on both those critical fronts. More than 1 million J&J doses that should have already been put to use remain on …

Norway's Committee Recommends Dropping AstraZeneca, J&J Covid Vaccine Jabs
3 years, 7 months ago

Norway's Committee Recommends Dropping AstraZeneca, J&J Covid Vaccine Jabs

News 18  

An expert committee set up by Norway’s government to evaluate AstraZeneca’s and Johnson & Johnson’s Covid-19 vaccines said on Monday that both should be abandoned over risks of rare but serious side effects. From the 134,000 injections of AstraZeneca’s vaccine administered in Norway up until mid-March, five cases of severe thrombosis — three of them fatal — were reported in …

South Africa resumes giving J&J jabs to health care workers
3 years, 7 months ago

South Africa resumes giving J&J jabs to health care workers

Associated Press  

JOHANNESBURG — South Africa has resumed giving the Johnson & Johnson vaccine to health care workers after a more than two-week pause in the use of the only COVID-19 inoculation in the country. South Africa on Wednesday restarted its drive to inoculate 1.2 million health care workers with the J&J vaccine. Before the halt, South Africa had given more than …

April 26, 2021 coronavirus news
3 years, 7 months ago

April 26, 2021 coronavirus news

CNN  

Fewer new people are getting their first Covid-19 shot than those finishing up their second, according to data from the US Centers for Disease Control and Prevention. For 10 of the last 11 days, the number of “fully vaccinated” people has risen more than the number of people with “at least one dose” — suggesting that second doses are outpacing …

California’s COVID-19 vaccination pace slowed after Johnson & Johnson pause, data show
3 years, 7 months ago

California’s COVID-19 vaccination pace slowed after Johnson & Johnson pause, data show

LA Times  

California’s COVID-19 inoculation pace tailed off after officials paused use of the Johnson & Johnson vaccine as a precaution earlier this month, according to data compiled by The Times. “To end this pandemic, we need to use every dose we have — and the Johnson & Johnson vaccine is a critical piece of that strategy,” Mayor Eric Garcetti said in …

US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots
3 years, 8 months ago

US to resume Johnson & Johnson COVID-19 vaccinations despite rare risk of blood clots

Firstpost  

Washington: US health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack …

US to resume J&J COVID vaccinations despite rare clot risk
3 years, 8 months ago

US to resume J&J COVID vaccinations despite rare clot risk

Associated Press  

U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson’s single-dose shot on Friday, after scientific advisers decided its benefits outweigh a rare risk of blood clot. CDC Director Dr. Rochelle Walensky added that the pause should increase confidence in vaccine safety, showing “that we are taking every one of those needles in a haystack that …

Johnson & Johnson's COVID-19 Vaccine Is Back In Use In The U.S.
3 years, 8 months ago

Johnson & Johnson's COVID-19 Vaccine Is Back In Use In The U.S.

NPR  

Johnson & Johnson's COVID-19 Vaccine Is Back In Use In The U.S. Federal health officials have lifted the pause on use of the Johnson & Johnson vaccine. SCOTT SIMON, HOST: The Johnson & Johnson vaccine is back in use in the U.S. Last night, officials from the Centers for Disease Control and Prevention and the Food and Drug Administration lifted …

April 23, 2021, Covid-19 vaccine and world news
3 years, 8 months ago

April 23, 2021, Covid-19 vaccine and world news

CNN  

In this March 3 photo, a pharmacist holds a vial of the Johnson & Johnson Covid-19 vaccine at a hospital in Bay Shore, New York. AP Photo/Mark Lennihan A subcommittee of vaccine advisers to US Centers for Disease Control and Prevention will recommend Friday that the Johnson & Johnson Covid-19 vaccine continue to be used in the United States, an …

April 23, 2021, Covid-19 vaccine and world news
3 years, 8 months ago

April 23, 2021, Covid-19 vaccine and world news

CNN  

In this March 3 photo, a pharmacist holds a vial of the Johnson & Johnson Covid-19 vaccine at a hospital in Bay Shore, New York. AP Photo/Mark Lennihan A subcommittee of vaccine advisers to US Centers for Disease Control and Prevention will recommend Friday that the Johnson & Johnson Covid-19 vaccine continue to be used in the United States, an …

U.S. lifts pause on J&J vaccinations, clearing the way for shots to resume
3 years, 8 months ago

U.S. lifts pause on J&J vaccinations, clearing the way for shots to resume

LA Times  

Johnson & Johnson’s COVID-19 vaccine will be back in circulation this weekend after the U.S. Centers for Disease Control and Prevention accepted an advisory panel’s decision that the disease-fighting benefits of the shots outweighed the risks. The CDC’s action lifted a 10-day pause that went into effect April 13 after federal safety monitors received reports of a rare but potentially …

US has more than 9 million Johnson & Johnson doses ready to go now that pause is lifted
3 years, 8 months ago

US has more than 9 million Johnson & Johnson doses ready to go now that pause is lifted

CNN  

CNN — The US has more than 9 million doses of Johnson & Johnson’s coronavirus vaccine ready to be administered now that federal health agencies have signed off on resuming use of the one-shot vaccine, CNN has learned. “I support the ACIP’s recommendation that the Johnson and Johnson COVID-19 vaccine be used for persons 18 years of age or older …

‘J&J jab, clots linked’
3 years, 8 months ago

‘J&J jab, clots linked’

Hindustan Times  

The EU’s drug regulatory agency said on Tuesday that it found a “possible link” between Johnson & Johnson’s Covid-19 vaccine and rare blood clots, and that a warning should be added to the label. Last week, J&J halted its vaccine’s European roll-out after US officials recommended a pause in its use when they detected six clot cases among almost 7 …

EU regulator finds possible link between Johnson & Johnson vaccine and blood clots, but says benefits outweigh risks
3 years, 8 months ago

EU regulator finds possible link between Johnson & Johnson vaccine and blood clots, but says benefits outweigh risks

CNN  

London CNN — Europe’s medicines regulator said it has found a possible link between the Johnson & Johnson Covid-19 vaccine and rare blood clots, but emphasized that the overall benefits of getting the shot outweigh the risks. The European Medicines Agency concluded that “a warning about unusual blood clots with low blood platelets should be added to the product information” …

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots
3 years, 8 months ago

EU regulator finds possible link between Johnson & Johnson COVID shot, blood clots

LA Times  

Experts at the agency that regulates drugs for the European Union said Tuesday that they found a “possible link” between the Johnson & Johnson COVID-19 vaccine and very rare blood clots after a small number of cases were reported in the U.S., but they confirmed that the vaccine’s benefits still outweighed the very small risks of recipients developing the unusual …

CDC vaccine advisers will meet Friday to discuss the J&J vaccine. Here’s what could happen next
3 years, 8 months ago

CDC vaccine advisers will meet Friday to discuss the J&J vaccine. Here’s what could happen next

CNN  

CNN — Vaccine advisers to the Centers for Disease Control and Prevention meet Friday to make recommendations for use of the Johnson & Johnson Covid-19 vaccine after it was put on hold to investigate a potential link to serious blood clots. The CDC and US Food and Drug Administration recommended a pause on use of the J&J coronavirus vaccine last …

EU regulator finds J&J vaccine has ‘possible link’ to blood clots
3 years, 8 months ago

EU regulator finds J&J vaccine has ‘possible link’ to blood clots

Al Jazeera  

The European Union’s medicines regulator on Tuesday said it had found a “possible link” between Johnson & Johnson’s COVID-19 vaccine and the development of rare blood clots in a small number of recipients, but concluded the shot’s overall benefits outweigh any risks associated with its use. The European Medicines Agency said its safety committee decided that a warning about unusual …

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots
3 years, 8 months ago

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots

NPR  

EU Regulator: 'Possible Link' Between Johnson & Johnson Vaccine And Rare Blood Clots Enlarge this image toggle caption Allen J. Schaben/Los Angeles Times via Getty Images Allen J. Schaben/Los Angeles Times via Getty Images The European Union's drug regulator said Tuesday it had concluded there is a "possible link" between the Johnson & Johnson COVID-19 vaccine and several cases in …

Covid: No new blood clots in Johnson & Johnson vaccine patients have been confirmed, CDC says
3 years, 8 months ago

Covid: No new blood clots in Johnson & Johnson vaccine patients have been confirmed, CDC says

Daily Mail  

No new cases of rare, life-threatening blood clots in recipients of Johnson & Johnson's COVID-19 vaccine have been confirmed, Centers for Disease Control and Prevention officials said Monday - but they are keeping a close eye out for them. SCROLL DOWN FOR THE VIDEO CDC director Dr Rochelle Walensky said on Monday the agency is looking into additional reports of …

Johnson & Johnson seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licence
3 years, 8 months ago

Johnson & Johnson seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licence

India TV News  

Multinational pharma giant johnson and johnson has applied to India's drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said. Such vaccines will be given emergency use approval mandating the requirement of post-approval parallel bridging clinical trial in place of conduct of local clinical trial under the …

Health officials considered issuing a warning before deciding to recommend a pause of the Johnson &Johnson Covid-19 vaccine
3 years, 8 months ago

Health officials considered issuing a warning before deciding to recommend a pause of the Johnson &Johnson Covid-19 vaccine

CNN  

CNN — As health officials discussed how to handle reports of blood clots possibly linked to Johnson & Johnson’s Covid-19 vaccine, one option considered was issuing a warning to health care providers without recommending a full pause, multiple sources told CNN. The CDC and FDA last week recommended that the United States pause the use of Johnson & Johnson’s Covid-19 …

Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they’re wrong.
3 years, 8 months ago

Johnson & Johnson said blood clots have been reported with all Covid-19 vaccines. The author of the study they cited says they’re wrong.

CNN  

CNN — When news broke that Johnson & Johnson’s Covid-19 vaccine might be linked to blood clots, the company responded by pointing a finger at Pfizer and Moderna’s vaccines, issuing a media statement that said a study showed there were reports of blood clots with their vaccines as well. “We didn’t find anyone with blood clots,” Dr. Eun-Ju Lee, an …

Fauci predicts J&J vaccine to come back to market with restrictions or warnings by Friday
3 years, 8 months ago

Fauci predicts J&J vaccine to come back to market with restrictions or warnings by Friday

CNN  

CNN — Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said Sunday that he expects a decision to be made about the Johnson & Johnson Covid-19 vaccine by Friday, predicting the vaccine would come back on the market with restrictions or warnings. “I don’t want to get ahead of the CDC and the FDA and …

U.S. pause on Johnson & Johnson vaccine could be felt the most in poor countries
3 years, 8 months ago

U.S. pause on Johnson & Johnson vaccine could be felt the most in poor countries

LA Times  

More than a billion people around the world have been waiting for the Johnson & Johnson vaccine — a cheap, easy-to-transport, one-dose injection that reduces the risk from COVID-19. The U.S. Food and Drug Administration, which this week recommended that use of the vaccine be paused while scientists study a possible link to extremely rare blood clots, has no authority …

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks
3 years, 8 months ago

Pfizer and Moderna DECLINED joining Johnson & Johnson study of vaccine blood clot risks

Daily Mail  

Johnson & Johnson privately reached out to rival COVID-19 vaccine makers to join in an effort to study the risks of blood clots. It comes as a pause of J&J's vaccine continues in the U.S. after multiple people developed rare, but serious, blood clots within days of receiving the shot. Johnson & Johnson privately asked other vaccine manufacturers to join …

Johnson & Johnson sought help from vaccine rivals after blood clot concerns emerged with its own immunizations
3 years, 8 months ago

Johnson & Johnson sought help from vaccine rivals after blood clot concerns emerged with its own immunizations

CNN  

New York CNN — Johnson & Johnson sought help from its three rival Covid-19 vaccine makers to look into reports of blood clots, but Pfizer and Moderna both declined, the Wall Street Journal reported on Friday, citing people familiar with the situation. Johnson & Johnson told CNN in an email that “the safety of the patients who use our products …

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?
3 years, 8 months ago

The dilemma in pausing J&J vaccine over risk of blood clots: Will it save lives or cost them?

LA Times  

“Do no harm.” The phrase, from the Hippocratic oath, is the guiding principle of medical care. “I would characterize it as wrenching,” Vanderbilt University vaccine expert Dr. William Schaffner said of the meeting, which he attended as a nonvoting representative of the National Foundation for Infectious Diseases. In addition, many men with unusual blood clots have shown up in Europe …

J&J pitched vaccine makers industrywide probe on blood clots: WSJ
3 years, 8 months ago

J&J pitched vaccine makers industrywide probe on blood clots: WSJ

Al Jazeera  

Johnson & Johnson has reached out to other coronavirus vaccine makers to join a study on blood-clot risks, The Wall Street Journal reported Friday, citing several people familiar with the matter. Johnson & Johnson has reached out to other coronavirus vaccine makers to join a study on the risks of blood clots, The Wall Street Journal reported on Friday, citing …

Discover Related